Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 5:17 PM
Ignite Modification Date:
2025-12-26 @ 5:17 PM
NCT ID:
NCT05772806
Eligibility Criteria:
Inclusion Criteria:
* Patients between 65-85 years old
* Patients in Q4 (highest risk) of Atrial Fibrillation (AF). \[Clua-Espuny et al, 2020\]
* CHADsVASc ≥ 2
* Being capable of using a Smart phone (or the care giver)
Exclusion Criteria:
* Patients with previous diagnostic of AF, stroke, or dementia.
* Patients treated with anticoagulants.
* Vital prognosis less than one year.
* Severe cognitive or functional impairment (GDS ≥ 3, and/or Barthel score ≤60, or MRS Rankin ≥4, or severe mobility impairment)
* Pacemaker Carrier
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
65 Years
Maximum Age:
85 Years
Study:
NCT05772806
Study Brief:
Protocol Section:
NCT05772806